Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac

University Hospital, Rouen236 enrolled

Overview

The main objective of the study is to estimate the proportion of children, born between the 01/01/2002 and the 06/23/200, living around Dieppe (cantons Dieppe est, Dieppe Ouest and Offranville), vaccinated by MenBVac, with a serum bactericidal activity against B:14,P1-7,16 clone related to a protection (\>= 4), before and after the third MenBvac vaccination.

Study Type

OBSERVATIONAL

Enrollment

236

Conditions

Vaccination

Eligibility

Sex: ALLMin age: 2 YearsMax age: 7 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * children born between 01/01/2000 and 06/23/2005, living in Dieppe-Est, Dieppe-Ouest and Offranville, vaccinated twice by MenBVac * parental authority(ies)assent Exclusion Criteria: * no parental authority(ies)assent * no blood sample during the third vaccination * impossibility of third vaccination

Locations (1)

UH-rouen

Rouen, Seine Maritime, France

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.